Lymphopenia Clinical Trials in Bethesda, Maryland
2 recruitingBethesda, Maryland
Showing 1–2 of 2 trials
Recruiting
Phase 1
Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled1 locationNCT04097561
Recruiting
Phase 1Phase 2
A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID)60 enrolled1 locationNCT05600920